Search

Your search keyword '"Galicier, Lionel"' showing total 963 results

Search Constraints

Start Over You searched for: Author "Galicier, Lionel" Remove constraint Author: "Galicier, Lionel"
963 results on '"Galicier, Lionel"'

Search Results

1. Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

3. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

6. Pregnancy in primary immunodeficiency diseases: The PREPI study

7. Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

8. Lymphoma as an Exclusion Criteria for CVID Diagnosis Revisited

9. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

10. Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease

13. Reconstitution of HIV-1 reservoir following high-dose chemotherapy/autologous stem cell transplantation for lymphoma

15. Combined Flow‐Fluorescence in situ hybridization to HHV‐8 and EBV reveals the viral heterogeneity of primary effusion lymphoma.

16. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

17. Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009- 2017

19. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

20. A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP

22. Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival

25. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France

26. Synergistic convergence of microbiota-specific systemic IgG and secretory IgA

27. Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura

29. Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients

30. Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

31. S232: EFFICACY AND TOXICITY OF CAR-T CELLS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS, A NEW REFERENCE: THE FRENCH EXPERIENCE OF THE NATIONAL LOC NETWORK

32. Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease

36. Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study.

37. Skin involvement in systemic lymphoma of follicular helper T‐cell origin: A cohort study of 57 patients.

38. Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

39. Reply to Zhou et al. ‘A novel approach for characterization of KSHV ‐associated multicentric Castleman disease from effusions’

41. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study

42. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy

45. O-129 - Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients

46. Severe SARS‐CoV‐2 infection in rituximab‐treated patients with autoimmune cytopenia: A multicenter observational study.

47. Severe chronic primary neutropenia in adults: report on a series of 108 patients

49. Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease

50. Characteristics of Circulating KSHV-Infected Cells during Active KSHV+ Multicentric Castleman Disease

Catalog

Books, media, physical & digital resources